USP revises Chapter <1231> on Pharmaceutical Water
Recommendation
22/23 September 2026
Organisation of a GMP-compliant Site Change
On the Road to 30,000 Members
Let us become the World's Leading GMP/GDP Compliance Community in 2026
Changes to the fundamental monograph on pharmaceutical water <1231> Water for Pharmaceutical Purposes from the US-American Pharmacopeia have been published for comments in the Pharmacopeial Forum 41(5). The revision presented in the current draft mainly has a structural nature. The content of the monograph has been reorganised in 9 new chapters which aim at improving readibility and searchability of the content searched:
1. INTRODUCTION
2. SOURCE WATER CONSIDERATIONS
3. WATERS USED FOR PHARMACEUTICAL MANUFACTURING AND TESTING PURPOSES
4. VALIDATION AND QUALIFICATION OF WATER PURIFICATION, STORAGE, AND DISTRIBUTION SYSTEMS
5. DESIGN AND OPERATION OF PURIFIED WATER AND WATER FOR INJECTION SYSTEMS
6. SAMPLING
7. CHEMICAL EVALUATIONS
8. MICROBIAL EVALUATIONS
9. ALERT AND ACTION LEVELS AND SPECIFICATIONS
The draft document is available for free on the website of the USP Pharmacopeial Forum. You only need to register for free. The deadline for comments is 20 November 2015.
Related GMP News
12.08.2026European Inspection uncovers serious Deficiencies at Indian Sterile Manufacturer
05.08.2026ASME BPE-2026: Overview of the Key Updates
05.08.2026Warning Letter to an Indian Manufacturer of OTC Products
29.07.2026What are the Requirements for the Manufacture of Solid Dosage Forms in Pharmaceutical Production?
29.07.2026WHO finalises Paper on Continuous Manufacturing
22.07.2026Deviations in Aseptic Manufacturing: Warning Letter to a Japanese Pharmaceutical Manufacturer